Published in J Burn Care Rehabil on August 26, 1987
Mechanisms of immune resolution. Crit Care Med (2003) 0.85
PATHOLOGICAL ASPECTS OF THE ANTI-INFLAMMATORY/IMMUNE SUPPRESSIVE RESPONSE IN SEPSIS AND SHOCK. Rec Res Dev Immunol (2003) 0.75
Thymus-marrow cell combinations. Synergism in antibody production. Proc Soc Exp Biol Med (1966) 10.03
Immunologic complementation between thymus and marrow cells--a model for the two-cell theory of immunocompetence. Transplant Rev (1969) 6.39
Cardiopulmonary resuscitation by medical and surgical house-officers. Lancet (1981) 6.33
Corticosteroids and lymphoid cells. N Engl J Med (1972) 5.69
Immunocompetence of transferred thymus-marrow cell combinations. J Immunol (1966) 4.52
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen. J Exp Med (1979) 3.35
Single-sample diagnosis of recent rubella by fractionation of antibody on Sephadex G-200 column. J Clin Pathol (1971) 2.84
Hydrocortisne resistance of graft vs host activity in mouse thymus, spleen and bone marrow. J Immunol (1970) 2.83
Thymus-marrow immunocompetence. V. Hydrocortisone-resistant cells and processes in the hemolytic antibody response of mice. J Exp Med (1971) 2.46
Video recording trauma resuscitations: an effective teaching technique. J Trauma (1988) 2.44
Electroimmunodiffusion (EID): a simple, rapid method for quantitation of immunoglobulins in dilute biological fluids. J Lab Clin Med (1967) 2.37
Tolerance and contact sensitivity to DNFB in mice. 3. Transfer of tolerance with "suppressor T cells". J Immunol (1974) 2.25
Tolerance and contact sensitivity to DNFB in mice. I. In vivo detection by ear swelling and correlation with in vitro cell stimulation. J Immunol (1974) 2.18
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J Exp Med (1979) 2.09
Bone marrow and spleen: dissociation of immunologic properties by cortisone. Science (1970) 2.02
Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide. J Immunol (1977) 1.87
A splenic requirement for the generation of suppressor T cells. J Immunol (1977) 1.86
Suppressive mechanisms involving sensitization and tolerance in contact allergy. Immunol Rev (1980) 1.72
How corticosteroids work. J Allergy Clin Immunol (1975) 1.70
The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction. J Immunol (1976) 1.68
Corticosteroids and lymphoid cells in vitro. I. Hydrocortisone lysis of human, guinea pig, and mouse thymus cells. J Lab Clin Med (1971) 1.66
The induction of hapten-specific T cell tolerance using hapten-modified lymphoid membranes. II. Relative roles of suppressor T cells and clone inhibition in the tolerant state. Eur J Immunol (1977) 1.66
The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma (1991) 1.64
Control of experimental contact sensitivity. Adv Immunol (1980) 1.54
Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg (1976) 1.50
Prospective, randomized trial of hypertonic sodium lactate versus lactated Ringer's solution for burn shock resuscitation. J Trauma (1989) 1.47
Site of action of cortisol in cellular immunity. J Immunol (1973) 1.46
Associations among PH and SH3 domain-containing proteins and Rho-type GTPases in Yeast. J Cell Biol (1996) 1.46
Thymus-derived lymphocytes and hydrocortisone: identification of subsets of theta-bearing cells and redistribution to bone marrow. Cell Immunol (1972) 1.43
Gastrointestinal involvement in leukocytoclastic vasculitis and polyarteritis nodosa. J Rheumatol (1981) 1.42
Influence of head and neck position on endotracheal tube tip position on chest x-ray examination: a potential problem in the infant undergoing intubation. J Burn Care Rehabil (1995) 1.39
Anti-immunoglobulin stimulation of murine lymphocytes. I. Age dependency of the proliferative response. J Immunol (1976) 1.39
Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. Genes Dev (1997) 1.39
Treatment of burned mice with hyperbaric oxygen reduces mesenteric bacteria but not pulmonary neutrophil deposition. Arch Surg (1994) 1.38
Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res (2000) 1.37
Human thymus cell cultures-evidence for two functional populations. Proc Soc Exp Biol Med (1966) 1.36
Immunologic reactions to haptens on autologous carriers. I. Participation of both thymus-derived and bone marrow-derived cells in the secondary in vitro response. J Exp Med (1973) 1.36
Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med (1985) 1.34
Suppressor T cell mechanisms in contact sensitivity. I. Efferent blockade by syninduced suppressor T cells. J Immunol (1978) 1.31
Isolation and properties of rex - mutants of bacteriophage lambda. J Virol (1972) 1.30
Migration of antibody-forming cells and antigen-sensitive precursors between spleen, thymus and bone marrow. Immunology (1968) 1.27
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol (1994) 1.26
Serum immunoglobulins in rheumatoid arthritis. J Lab Clin Med (1966) 1.25
Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA. J Immunol (1985) 1.24
Tolerance and contact sensitivity to DNFB in mice. V. Induction of tolerance with DNP compounds and with free and membrane-associated DNFB. J Immunol (1976) 1.22
H-2 restriction of suppressor T-cell induction by hapten-modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitization. J Exp Med (1977) 1.20
Subpopulations of mouse T lymphocytes. I. "Thymidine suicide" of a major proliferating, PHA-responsive cell population present in spleen but not in lymph node. J Immunol (1974) 1.19
Regulation of cell mediated immunity by antibodies: possible role of anti-receptor antibodies in the regulation of contact sensitivity to DNFB in mice. J Immunol (1979) 1.19
Tolerance: two pathways of negative immunoregulation in contact sensitivity to DNFB. Cold Spring Harb Symp Quant Biol (1977) 1.19
Serum immunoglobulin measurement during the first year of life and in immunoglobulin-deficiency states. J Pediatr (1966) 1.18
Immunity tolerance to a hapten (NIP) coupled to an isologous carrier (mouse gamma globulin). J Exp Med (1972) 1.18
Requirements for induction of T cell tolerance to DNFB: efficiency of membrane-associated DNFB. J Immunol (1976) 1.16
Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems. Cell Immunol (1983) 1.15
Inhibition of antibody production and acquired immunologic tolerance by actinomycin. J Immunol (1965) 1.12
Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn wounds. J Trauma (1987) 1.11
Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate. Surgery (1988) 1.08
Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. J Biomed Mater Res (1988) 1.08
Tolerance and contact sensitivity to DNFB in mice. II. Specific in vitro stimulation with a hapten, 2,4-dinitrobenzene sulfonic acid (DNB-SO3Na). J Immunol (1974) 1.04
Thymus-marrow immunocompetence. IV. The growth and immunocompetence of transferred marrow, thymus, and spleen cells in parent and F1 hybrid mice. Transplantation (1969) 1.04
Age-related changes in cell-mediated immunity in BALB/C mice. J Immunol (1975) 1.03
Comparison of Biobrane and Scarlet Red dressings for treatment of donor site wounds. Arch Surg (1985) 1.02
Conservative management of sand aspiration: case report. Mil Med (1984) 1.02
Human necrotizing vasculitis: immunoglobulins and complement in vessel walls of cutaneous lesions and normal skin. J Invest Dermatol (1975) 1.02
Changes in serum immunoglobulin and complement levels following renal homotransplantation. Transplantation (1970) 1.02
Suppressor T cell circuits in contact sensitivity. I. Two mechanistically distinct waves of suppressor T cells occur in mice tolerized with syngeneic DNP-modified lymphoid cells. J Immunol (1982) 1.01
Quantitation of immunoglobulins in cerebrospinal fluid. Arch Neurol (1966) 1.01
Use of overhead hooks in burn surgery. J Burn Care Rehabil (1989) 1.01
Mast cell "disappearance" in chronic murine graft-vs-host disease (GVHD)-ultrastructural demonstration of "phantom mast cells". J Immunol (1986) 1.01
Isolated severe gamma A deficiency: immunoglobulin levels, clinical disorders, and chromosome studies. J Lab Clin Med (1970) 1.00
The response of cultured human thymus cells to phytohemagglutinin. J Immunol (1968) 0.99
Efficient induction of immediate tolerance to contact sensitivity by hapten-modified spleen cells requires Ia+ cells compatible with recipient. Nature (1979) 0.99
Reduction of bacterial translocation and intestinal structural alterations by heparin in a murine burn injury model. J Trauma (1994) 0.98
Histiocytic reaction in dysgammaglobulinemia and congenital rubella. Pediatrics (1970) 0.97
Placement of 10-gauge catheter by cutdown for rapid fluid replacement. J Trauma (1983) 0.97
Amyloid-associated muscle pseudohypertrophy. Arch Neurol (1982) 0.97
Bone marrow T cells. II. Thymic dependency. Cell Immunol (1974) 0.97
Suppressor T cell mechanisms in contact sensitivity. II. Afferent blockade by alloinduced suppressor T cells. J Immunol (1978) 0.96
Regulation of granulopoiesis following severe thermal injury. J Trauma (1983) 0.96
Cortisol inhibition of immunologic activity in guinea pig alveolar cells. Int Arch Allergy Appl Immunol (1974) 0.96
Altered helper and suppressor lymphocyte populations in surgical patients. A measure of postoperative immunosuppression. Am J Surg (1984) 0.95
Vasculitis in chronic urticaria. J Allergy Clin Immunol (1980) 0.95
Immunosuppression by hyperbaric oxygen. Surgery (1980) 0.95
Hypogammaglobulinemia, primary and secondary: immunoglobulin levels (gamma-G, gamma-A, gamma-M) in one hundred and twenty-five patients. J Allergy (1966) 0.95
Postburn immunosuppression in an animal model. II. Restoration of cell-mediated immunity by immunomodulating drugs. Surgery (1984) 0.95
Cell-cell interactions in antibody production. Prog Allergy (1972) 0.95
Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis. Cell Immunol (1985) 0.95
A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil (1997) 0.94
Salivary immunoglobulin and albumin: development during the newborn period. J Pediatr (1968) 0.94
Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies. J Invest Dermatol (1977) 0.93
Role of melanoma growth stimulatory activity (MGSA/gro) on keratinocyte function in wound healing. Arch Dermatol Res (1997) 0.93
Postburn immunosuppression in an animal model: monocyte dysfunction induced by burned tissue. Surgery (1983) 0.93
Hypothesis. T-cell tolerance--one signal? Cell Immunol (1979) 0.92
Skin wound closure in athymic mice with cultured human cells, biopolymers, and growth factors. Surgery (1991) 0.92
In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials (1991) 0.92